Hansen, A. L., Andersen, M. K., Engelhard, L. M., Brøns, C., Hansen, T., Nielsen, J. S., Vestergaard, P., Højlund, K., Jessen, N., Olsen, M. H., Thomsen, R. W. & Vaag, A. (2025). Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 27(4), 2002-2011. https://doi.org/10.1111/dom.16193

on behalf of Danish Thyroid Cancer Group (DATHYRCA) (2025). RET C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Study. Cancers, 17(3), Article 374. https://doi.org/10.3390/cancers17030374

Hansen, C. S., Christensen, M. M. B., Vistisen, D., Jepsen, R., Ellervik, C., Jørgensen, M. E. & Fleischer, J. (2025). Normative data on measures of cardiovascular autonomic neuropathy and the effect of pretest conditions in a large Danish non-diabetic CVD-free population from the Lolland-Falster Health Study. Clinical Autonomic Research, 35(1), 101-113. https://doi.org/10.1007/s10286-024-01069-6

Hartz, M. C., Johannessen, F. B., Harsløf, T. & Langdahl, B. L. (2025). The Effectiveness and Safety of Romosozumab and Teriparatide in Postmenopausal Women with Osteoporosis. The Journal of clinical endocrinology and metabolism, 110(5), e1640-e1652. https://doi.org/10.1210/clinem/dgae484

Hjelholt, A. J., Bach, F. W., Kasch, H., Støvring, H., Jensen, T. S. & Jørgensen, J. O. L. (2025). Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial. PLOS ONE, 20(4 April), Article e0320937. https://doi.org/10.1371/journal.pone.0320937

Hofmann, R., James, S., Sundqvist, M. O., Wärme, J., Fröbert, O., Angerås, O., Hellström, P. M., Hambraeus, K., Alfredsson, J., Erlinge, D., Lauermann, J., Lindhagen, L., Östlund, O., Jernberg, T. & Bäck, M. (2025). HELicobacter Pylori screening to prevent gastrointestinal bleeding in patients with acute Myocardial Infarction (HELP-MI SWEDEHEART) - Design and rationale of a cluster randomized, crossover, registry-based clinical trial. American Heart Journal, 286, 66-74. https://doi.org/10.1016/j.ahj.2025.03.014

Holm, J. B., Bruun, J. M., Christiansen, P., Thomsen, R. W., Frystyk, J., Cronin-Fenton, D. & Borgquist, S. (2025). HbA_1c levels and breast cancer prognosis in women without diabetes. BMC Cancer, 25(1), Article 790. https://doi.org/10.1186/s12885-025-14121-z

Høyer, K. L., Dahl Baunwall, S. M., Kornum, D. S., Klinge, M. W., Drewes, A. M., Yderstræde, K. B., Thingholm, L. B., Mortensen, M. S., Mikkelsen, S., Erikstrup, C., Hvas, C. L. & Krogh, K. (2025). Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial. EClinicalMedicine, 79, 103000. Article 103000. https://doi.org/10.1016/j.eclinm.2024.103000, https://doi.org/10.1016/j.eclinm.2024.103000

Jäger, S., Kuxhaus, O., Prada, M., Huybrechts, I., Tong, T. Y. N., Forouhi, N. G., Razquin, C., Corella, D., Martinez-Gonzalez, M. A., Dahm, C. C., Ibsen, D. B., Tjønneland, A., Halkjær, J., Marques, C., Cadeau, C., Ren, X., Katzke, V., Bendinelli, B., Agnoli, C. ... Schulze, M. B. (2025). Nut consumption, linoleic and α-linolenic acid intakes, and genetics: how fatty acid desaturase 1 impacts plasma fatty acids and type 2 diabetes risk in EPIC-InterAct and PREDIMED studies. BMC Medicine, 23(1), Article 344. https://doi.org/10.1186/s12916-025-04187-8

Jensen, M. H., Gasbjerg, L. S., Skov-Jeppesen, K., Jacobsen, J. C. B., Poulsen, S. S., Zhou, C., Jakubauskaite, R., Poulsen, F. R., Bonde, C., Albarazi, M., Halle, B., Christiansen, C. B., Sanni, S. J., Byberg, S., Hoe, B., Holst, J. J., Dela, F., Rasmussen, A. K., Knop, F. K. ... Rosenkilde, M. M. (2025). GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly. The Journal of clinical endocrinology and metabolism, 110(3), 715-729. https://doi.org/10.1210/clinem/dgae583